Prescribing information

Preview a range of resources designed to support you and your GILENYA®▼ (fingolimod) patients during face-to-face or virtual conversations.Show more

Rate this content: 
Average: 5 (1 vote)
GIL19-C053e(2) November 2020.

Prescribing information

The patient support programme which offers patients and healthcare professionals access to nurses and specially developed materials to help patients through the first year of their GILENYA®▼ (fingolimod) journey.Show more

Rate this content: 
Average: 5 (1 vote)
GIL19-C053d(1) November 2020.
×

Ask Speakers

×

Medical Information Request

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Novartis via uk.patientsafety@novartis.com or online through the pharmacovigilance intake (PVI) tool at www.report.novartis.com
If you have a question about the product, please contact Medical Information on 01276 698370 or by email at medinfo.uk@novartis.com